ASTRIA THERAPEUTICS
Catabasis Pharmaceuticals is a biopharmaceutical company located in Cambridge, Massachusetts focused on the discovery and development of innovative drugs to treat inflammatory conditions. Their platform technology enables the discovery and development of small molecules that simultaneously and specifically target pathways in the inflammatory response. The Catabasis platform will lead to the development of a novel mechanism of action therapies to safely and effectively treat inflammatory diseases.
ASTRIA THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care Medical
Founded:
2008-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.astriatx.com
Total Employee:
11+
Status:
Active
Contact:
(617) 349-1971
Email Addresses:
[email protected]
Total Funding:
309.53 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail IPv6 Microsoft Azure DNS Google COVID-19 Mimecast Akamai Hosted InMotion Hosting
Similar Organizations
Anthos Therapeutics
Anthos Therapeutics is a biopharmaceutical company that specializes in the treatment of cardiovascular and metabolic diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Ceria Therapeutics
Ceria Therapeutics develops innovative and novel therapies to treat overactive and nonproductive inflammation to promote healing.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-01-29 | Quellis Biosciences | Quellis Biosciences acquired by Astria Therapeutics | N/A |
Investors List
Employee Stock Option Fund
Employee Stock Option Fund investment in Secondary Market - Astria Therapeutics
SV Health Investors
SV Health Investors investment in Series B - Astria Therapeutics
Advanced Technology Ventures
Advanced Technology Ventures investment in Series B - Astria Therapeutics
Lightstone Ventures
Lightstone Ventures investment in Series B - Astria Therapeutics
MedImmune Ventures
MedImmune Ventures investment in Series B - Astria Therapeutics
Clarus Ventures
Clarus Ventures investment in Series B - Astria Therapeutics
MedImmune Ventures
MedImmune Ventures investment in Venture Round - Astria Therapeutics
Advanced Technology Ventures
Advanced Technology Ventures investment in Venture Round - Astria Therapeutics
SV Health Investors
SV Health Investors investment in Venture Round - Astria Therapeutics
Clarus Ventures
Clarus Ventures investment in Venture Round - Astria Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-15 | Astria Therapeutics Names Chris Morabito Chief Medical Officer |
Official Site Inspections
http://www.astriatx.com Semrush global rank: 8.71 M Semrush visits lastest month: 262
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
